Free Trial

Best Penny Stocks Under 25 Cents Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25.

WW International stock logo

1. WW International NASDAQ:WW

$0.25 -0.03 (-10.51%)
As of 05/15/2025

WW International, Inc provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. More about WW International

Market Capitalization
$20.04 million
P/E Ratio
-0.04
Consensus Rating
Hold
Consensus Price Target
$2.25 (+801.4% Upside)
Volume
10.45 million shares
Average Volume
10.51 million shares
Sunnova Energy International stock logo

2. Sunnova Energy International NYSE:NOVA

$0.20 -0.01 (-4.27%)
As of 03:58 PM Eastern

Sunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy International

Market Capitalization
$25.34 million
P/E Ratio
-0.06
Consensus Rating
Hold
Consensus Price Target
$4.36 (+2,061.3% Upside)
Volume
3.72 million shares
Average Volume
10.98 million shares
Nikola stock logo

3. Nikola NASDAQ:NKLA

$0.18 -0.07 (-28.74%)
Closing price 02/25/2025
Extended Trading
$0.18 0.00 (0.00%)
As of 02/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about Nikola

Market Capitalization
$11.14 million
P/E Ratio
-0.01
Consensus Rating
Hold
Consensus Price Target
$6.00 (+3,178.7% Upside)
Volume
36.66 million shares
Average Volume
9.19 million shares
Affimed stock logo

4. Affimed NASDAQ:AFMD

$0.18 -0.10 (-34.95%)
As of 05/19/2025 04:00 PM Eastern

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. More about Affimed

Market Capitalization
$2.92 million
Consensus Rating
Hold
Consensus Price Target
$7.90 (+4,251.5% Upside)
Volume
22.99 million shares
Average Volume
4.21 million shares
Today's Range
$0.17
$0.24
Zapp Electric Vehicles Group stock logo

5. Zapp Electric Vehicles Group NASDAQ:ZAPP

$0.15 -0.13 (-46.31%)
As of 05/19/2025 04:00 PM Eastern

Zapp Electric Vehicles Group Ltd. engages in the provision of designs, manufactures and sells electric vehicles. It operates through the following geographical segments: Cayman Islands, Europe, and Thailand. More about Zapp Electric Vehicles Group

Market Capitalization
$1.23 million
Consensus Rating
Buy
Consensus Price Target
$3.00 (+1,838.0% Upside)
Volume
13.38 million shares
Average Volume
3.00 million shares
Today's Range
$0.14
$0.22
TruGolf stock logo

6. TruGolf NASDAQ:TRUG

$0.22 -0.01 (-5.33%)
As of 04:00 PM Eastern

TruGolf Holdings, Inc, through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States. More about TruGolf

Market Capitalization
$6.43 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$2.00 (+830.2% Upside)
Volume
727,225 shares
Average Volume
2.08 million shares
NuCana stock logo

7. NuCana NASDAQ:NCNA

$0.05 0.00 (-3.73%)
As of 04:00 PM Eastern

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. More about NuCana

Market Capitalization
$264 thousand
P/E Ratio
0.00
Consensus Rating
Moderate Buy
Consensus Price Target
$25.00 (+53,779.3% Upside)
Volume
74.57 million shares
Average Volume
9.03 million shares
Omega Therapeutics stock logo

8. Omega Therapeutics NASDAQ:OMGA

$0.12 -0.03 (-21.83%)
Closing price 02/24/2025
Extended Trading
$0.12 0.00 (0.00%)
As of 02/24/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega Therapeutics

Market Capitalization
$6.92 million
P/E Ratio
-0.09
Consensus Rating
Moderate Buy
Consensus Price Target
$9.20 (+7,260.0% Upside)
Volume
4.81 million shares
Average Volume
3.08 million shares
LanzaTech Global stock logo

9. LanzaTech Global NASDAQ:LNZA

$0.24 -0.01 (-4.00%)
As of 04:00 PM Eastern

LanzaTech Global, Inc operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. More about LanzaTech Global

Market Capitalization
$47.50 million
P/E Ratio
-0.37
Consensus Rating
Hold
Consensus Price Target
$2.00 (+733.3% Upside)
Volume
650,707 shares
Average Volume
1.23 million shares
Wag! Group stock logo

10. Wag! Group NASDAQ:PET

$0.15 0.00 (-0.88%)
As of 04:00 PM Eastern

Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! Group

Market Capitalization
$7.40 million
P/E Ratio
-0.37
Consensus Rating
Moderate Buy
Consensus Price Target
$4.13 (+2,727.3% Upside)
Volume
501,564 shares
Average Volume
1.88 million shares
IN8bio stock logo

11. IN8bio NASDAQ:INAB

$0.13 +0.01 (+4.00%)
As of 04:00 PM Eastern

IN8bio, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. More about IN8bio

Market Capitalization
$11.35 million
P/E Ratio
-0.17
Consensus Rating
Buy
Consensus Price Target
$6.00 (+4,515.4% Upside)
Volume
1.90 million shares
Average Volume
1.98 million shares
Syros Pharmaceuticals stock logo

12. Syros Pharmaceuticals NASDAQ:SYRS

$0.03 0.00 (-1.32%)
As of 03:38 PM Eastern

Syros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros Pharmaceuticals

Market Capitalization
$802 thousand
P/E Ratio
-0.01
Consensus Rating
Hold
Consensus Price Target
$3.33 (+11,048.3% Upside)
Volume
111,275 shares
Average Volume
8.09 million shares
Bio-Path stock logo

13. Bio-Path NASDAQ:BPTH

$0.19 -0.01 (-5.01%)
As of 03:09 PM Eastern

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. More about Bio-Path

Market Capitalization
$1.58 million
Consensus Rating
Buy
Consensus Price Target
$20.00 (+10,443.0% Upside)
Volume
2,772 shares
Average Volume
1.26 million shares
Today's Range
$0.17
$0.20
Beyond Air stock logo

14. Beyond Air NASDAQ:XAIR

$0.19 +0.00 (+1.53%)
As of 04:00 PM Eastern

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond Air

Market Capitalization
$16.64 million
P/E Ratio
-0.18
Consensus Rating
Buy
Consensus Price Target
$1.50 (+678.8% Upside)
Volume
874,462 shares
Average Volume
1.20 million shares
Lyra Therapeutics stock logo

15. Lyra Therapeutics NASDAQ:LYRA

$0.10 -0.01 (-9.82%)
As of 04:00 PM Eastern

Lyra Therapeutics, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. More about Lyra Therapeutics

Market Capitalization
$6.39 million
P/E Ratio
-0.06
Consensus Rating
Hold
Consensus Price Target
$2.00 (+1,974.7% Upside)
Volume
3.02 million shares
Average Volume
1.91 million shares
Lazydays stock logo

16. Lazydays NASDAQ:GORV

$0.19 -0.01 (-7.13%)
As of 04:00 PM Eastern

Lazydays Holdings, Inc operates recreational vehicle (RV) dealerships under the Lazydays name in the United States. The company offers RV sales, RV-repair and services, financing and insurance products, third-party protection plans, and after-market parts and accessories. More about Lazydays

Market Capitalization
$20.79 million
P/E Ratio
-0.01
Consensus Rating
Hold
Consensus Price Target
$2.00 (+959.3% Upside)
Volume
1.68 million shares
Average Volume
925,602 shares
Vor Biopharma stock logo

17. Vor Biopharma NYSE:VOR

$0.18 +0.00 (+1.71%)
As of 04:00 PM Eastern

Vor Biopharma Inc operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. More about Vor Biopharma

Market Capitalization
$22.31 million
P/E Ratio
-0.11
Consensus Rating
Hold
Consensus Price Target
$7.06 (+3,853.6% Upside)
Volume
1.59 million shares
Average Volume
957,227 shares
WonderFi Technologies stock logo

18. WonderFi Technologies OTCMKTS:WONDF

$0.24 +0.01 (+3.51%)
As of 03:58 PM Eastern

WonderFi Technologies Inc engages in the development and acquisition of technology platforms to facilitate investments in the emerging industry of digital assets. More about WonderFi Technologies

Consensus Rating
Hold
Volume
711,204 shares
Average Volume
669,160 shares
Today's Range
$0.23
$0.24
50-Day Range
$0.12
$0.25
52-Week Range
$0.09
$0.29
Aspira Women's Health stock logo

19. Aspira Women's Health NASDAQ:AWH

$0.08 -0.01 (-12.49%)
As of 04/16/2025

Aspira Women's Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. More about Aspira Women's Health

Market Capitalization
$2.44 million
P/E Ratio
-0.07
Consensus Rating
Buy
Consensus Price Target
$5.50 (+6,607.3% Upside)
Volume
4.31 million shares
Average Volume
1.34 million shares
T2 Biosystems stock logo

20. T2 Biosystems NASDAQ:TTOO

$0.16 0.00 (-0.61%)
As of 02:03 PM Eastern

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. More about T2 Biosystems

Market Capitalization
$3.44 million
Consensus Rating
Hold
Consensus Price Target
$5.00 (+2,958.1% Upside)
Volume
30,248 shares
Average Volume
593,411 shares
Today's Range
$0.14
$0.17
Cutera stock logo

21. Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about Cutera

Market Capitalization
$787 thousand
P/E Ratio
-0.01
Consensus Rating
Moderate Buy
Consensus Price Target
$3.00 (+7,592.3% Upside)
Volume
27.70 million shares
Average Volume
2.45 million shares
Palatin Technologies stock logo

22. Palatin Technologies NYSEAMERICAN:PTN

$0.10 -0.07 (-43.76%)
Closing price 05/7/2025
Extended Trading
$0.10 0.00 (0.00%)
As of 05/7/2025 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. More about Palatin Technologies

Market Capitalization
$2.49 million
P/E Ratio
-0.06
Consensus Rating
Buy
Consensus Price Target
$7.00 (+7,222.2% Upside)
Volume
14.57 million shares
Average Volume
978,456 shares
Carisma Therapeutics stock logo

23. Carisma Therapeutics NASDAQ:CARM

$0.18 -0.01 (-3.73%)
As of 04:00 PM Eastern

Carisma Therapeutics, Inc, a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. More about Carisma Therapeutics

Market Capitalization
$7.65 million
P/E Ratio
-0.12
Consensus Rating
Hold
Consensus Price Target
$1.93 (+951.3% Upside)
Volume
479,511 shares
Average Volume
440,013 shares
Leafly stock logo

24. Leafly NASDAQ:LFLY

$0.20 +0.02 (+10.39%)
As of 03:40 PM Eastern

Leafly Holdings, Inc owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. More about Leafly

Market Capitalization
$614 thousand
P/E Ratio
-0.09
Consensus Rating
Buy
Consensus Price Target
$9.18 (+4,494.6% Upside)
Volume
10,954 shares
Average Volume
362,293 shares
Ayr Wellness stock logo

25. Ayr Wellness OTCMKTS:AYRWF

$0.24 -0.02 (-8.49%)
As of 03:56 PM Eastern

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. More about Ayr Wellness

Market Capitalization
$28.18 million
P/E Ratio
-0.11
Consensus Rating
Moderate Buy
Consensus Price Target
$3.00 (+1,137.1% Upside)
Volume
112,080 shares
Average Volume
282,772 shares